Eike Burandt

4.4k total citations
68 papers, 1.6k citations indexed

About

Eike Burandt is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eike Burandt has authored 68 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 22 papers in Molecular Biology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eike Burandt's work include Cancer Genomics and Diagnostics (12 papers), Cervical Cancer and HPV Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Eike Burandt is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Cervical Cancer and HPV Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Eike Burandt collaborates with scholars based in Germany, United States and Switzerland. Eike Burandt's co-authors include Guido Sauter, Ronald Simon, Robert H. Young, Christoph Burdelski, Jeffrey B. Kaplan, Stefanie Scherpe, Lars Frommelt, A. Davies, Dietrich Mack and Llinos G. Harris and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Hepatology.

In The Last Decade

Eike Burandt

66 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eike Burandt Germany 22 706 427 334 288 241 68 1.6k
Dhirendra Govender South Africa 23 680 1.0× 506 1.2× 347 1.0× 388 1.3× 213 0.9× 88 1.7k
Isabelle Rooney United States 25 1.0k 1.4× 618 1.4× 374 1.1× 128 0.4× 104 0.4× 49 2.5k
Ming Guo United States 26 483 0.7× 493 1.2× 433 1.3× 477 1.7× 177 0.7× 90 2.0k
Masafumi Inoue Japan 20 440 0.6× 215 0.5× 246 0.7× 319 1.1× 73 0.3× 53 1.3k
Tianyu Tang China 19 592 0.8× 797 1.9× 281 0.8× 141 0.5× 62 0.3× 44 1.6k
Shannon R. Morris United States 23 980 1.4× 872 2.0× 354 1.1× 88 0.3× 81 0.3× 57 2.0k
Olivier Adotévi France 30 797 1.1× 1.3k 3.0× 263 0.8× 144 0.5× 97 0.4× 100 2.4k
Sylvie Caulet-Maugendre France 19 220 0.3× 474 1.1× 331 1.0× 129 0.4× 272 1.1× 45 1.6k
Rikke Fredslund Andersen Denmark 31 975 1.4× 964 2.3× 556 1.7× 173 0.6× 127 0.5× 115 2.8k
Albert Font Spain 17 640 0.9× 581 1.4× 506 1.5× 494 1.7× 44 0.2× 50 1.5k

Countries citing papers authored by Eike Burandt

Since Specialization
Citations

This map shows the geographic impact of Eike Burandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eike Burandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eike Burandt more than expected).

Fields of papers citing papers by Eike Burandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eike Burandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eike Burandt. The network helps show where Eike Burandt may publish in the future.

Co-authorship network of co-authors of Eike Burandt

This figure shows the co-authorship network connecting the top 25 collaborators of Eike Burandt. A scholar is included among the top collaborators of Eike Burandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eike Burandt. Eike Burandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viehweger, Florian, Franziska Büscheck, Till S. Clauditz, et al.. (2024). Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors. Biomedicines. 12(5). 957–957. 3 indexed citations
2.
Lennartz, Maximilian, Florian Viehweger, David Dum, et al.. (2023). Abstract 5457: Prevalence of “low” HER2 expression is frequent in breast cancer but also in cancers of other origin: A tissue microarray study on 131 tumor types. Cancer Research. 83(7_Supplement). 5457–5457. 1 indexed citations
3.
Singer, Christian F., Frederik Holst, Stefan Steurer, et al.. (2022). Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer. Clinical Cancer Research. 28(18). 4112–4120. 10 indexed citations
4.
Schmalfeldt, Barbara, Volkmar Müller, Linn Wölber, et al.. (2021). MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer. Pathology - Research and Practice. 224. 153533–153533. 3 indexed citations
5.
Bennett, Jennifer A., Zehra Ordulu, Robert H. Young, et al.. (2021). Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations. Modern Pathology. 34(9). 1750–1762. 24 indexed citations
6.
Prieske, Katharina, Malik Alawi, Anna Jaeger, et al.. (2021). Transcriptome Analysis in Vulvar Squamous Cell Cancer. Cancers. 13(24). 6372–6372. 4 indexed citations
7.
Dum, David, Stefan Steurer, Ronald Simon, et al.. (2021). Mismatch repair deficiency occurs very rarely in seminomas. Translational Andrology and Urology. 10(3). 1048–1055. 5 indexed citations
8.
Fraune, Christoph, Ronald Simon, Claudia Hube‐Magg, et al.. (2020). MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass. Urologic Oncology Seminars and Original Investigations. 38(5). 488–495. 19 indexed citations
9.
Eichenauer, Till, Martina Kluth, Cosima Göbel, et al.. (2020). Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma. World Journal of Surgical Oncology. 18(1). 128–128. 2 indexed citations
10.
Bennett, Jennifer A., Lauren L. Ritterhouse, Larissa V. Furtado, et al.. (2019). Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases. Modern Pathology. 33(4). 734–747. 27 indexed citations
11.
Grimm, Donata, et al.. (2019). Superficially invasive stage IA vulvar squamous cell carcinoma—therapy and prognosis. International Journal of Gynecological Cancer. 29(3). 466–473. 6 indexed citations
12.
Schroeder, Cornelia, Claudia Hube‐Magg, Martina Kluth, et al.. (2019). Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer. BMC Cancer. 19(1). 193–193. 22 indexed citations
13.
Woelber, Linn, Simon A. Joosse, Donata Grimm, et al.. (2018). Correlation of Isotope Count With Sentinel Node Positivity in Vulvar Cancer. International Journal of Gynecological Cancer. 28(7). 1403–1409. 2 indexed citations
14.
Göbel, Cosima, Martina Kluth, Christian Bernreuther, et al.. (2018). PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer. BMC Cancer. 18(1). 612–612. 12 indexed citations
15.
Burandt, Eike, Frederik Holst, F. Jänicke, et al.. (2013). Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer. Breast Cancer Research and Treatment. 137(3). 745–753. 33 indexed citations
16.
Schwinge, Dorothee, Tanja Schoknecht, Alexander Quaas, et al.. (2013). Increased T Helper Type 17 Response To Pathogen Stimulation in Patients With Primary Sclerosing Cholangitis. Hepatology. 58(3). 1084–1093. 121 indexed citations
17.
Minner, Sarah, Eike Burandt, Jens Köllermann, et al.. (2010). Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer. Clinical Cancer Research. 16(5). 1553–1560. 110 indexed citations
18.
Burandt, Eike & Guido Sauter. (2010). HER2-ASCO-Guidelines. Der Pathologe. 31(S2). 285–291. 8 indexed citations
19.
Zustin, Jozef, Maria Tsourlakis, Eike Burandt, et al.. (2009). HER-2/neu analysis in breast cancer bone metastases. Journal of Clinical Pathology. 62(6). 542–546. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dhirendra Govender Breakdown of academic impact, for papers by Isabelle Rooney Breakdown of academic impact, for papers by Ming Guo Breakdown of academic impact, for papers by Masafumi Inoue Breakdown of academic impact, for papers by Tianyu Tang Breakdown of academic impact, for papers by Shannon R. Morris Breakdown of academic impact, for papers by Olivier Adotévi Breakdown of academic impact, for papers by Sylvie Caulet-Maugendre Breakdown of academic impact, for papers by Rikke Fredslund Andersen Breakdown of academic impact, for papers by Albert Font
Rankless by CCL
2026